Frederick Lab and Georgetown launch research, education collaboration

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A collaboration between Georgetown University and the Frederick National Laboratory for Cancer Research aims to expand research and training missions in the biomedical sciences for both institutions.

Representatives from Georgetown and the Frederick National Laboratory signed a memorandum of understanding that paves the way for appointments and exchange of scientific staff, sabbatical opportunities, student training, postdoctoral fellowships and student internships aimed at enhancing the institutions’ quality of science, technology, and education.

The new framework builds on past collaborations between Georgetown and Frederick researchers and formalizes an ongoing relationship.

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login